Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Fundoplication Helps Relieve Refractory Heartburn

By HospiMedica International staff writers
Posted on 29 Oct 2019
For gastroesophageal reflux disease (GERD) patients that are refractory to proton pump inhibitors (PPIs), surgery offers the better option, according to a new study.

Researchers at Baylor University Medical Center (Dallas, TX, USA), the VA Office of Research and Development (Washington, DC, USA), the University of Maryland (Baltimore, USA), and other institutions conducted a study involving 78 patients referred to Veterans Affairs (VA) gastroenterology clinics for PPI-refractory heartburn, a frequent clinical problem with multiple causes. More...
Treatments for PPI-refractory heartburn are of unproven efficacy, and focus on controlling GERD with reflux-reducing medication (such as baclofen), antireflux surgery, or dampening visceral hypersensitivity with neuromodulators such as desipramine.

Study patients were randomly assigned to receive surgical treatment via laparoscopic fundoplication, medical treatment that included the PPI omeprazole plus baclofen (with desipramine added depending on symptoms), or to a control medical treatment (omeprazole plus placebo). The results revealed that the incidence of treatment success with surgery (67%) was significantly superior to that with active medical treatment (28%) or control medical treatment (12%). The study was published on October 16, 2018, in the New England Journal of Medicine (NEJM).

“GERD is an extremely common problem, and heartburn is the main symptom. PPIs are the best treatments we have, but as many as 30% of people still have symptoms when taking PPIs,” said lead author Stuart Jon Spechler, MD, chief of gastroenterology at Baylor University Medical Center. “There are a lot of other things that can cause that burning feeling, and patients can't tell if they have reflux or another kind of heartburn. If their heartburn isn't reflux-related, surgery won't provide relief. We only want to operate on the group that will benefit from the surgery.”

In GERD patients, the esophageal sphincter is weakened and does not close tightly, allowing digestive juices to return and irritate the esophageal lining. Treatment options usually include lifestyle changes, medications such as over-the-counter antacids and PPIs, and laparoscopic Nissen fundoplication to reinforce and strengthen the lower esophageal sphincter (LES). The procedure involves folding and wrapping the upper portion of the stomach around the lowest portion of the esophagus, much the way a bun wraps around a hot dog.

Related Links:
Baylor University Medical Center
VA Office of Research and Development
University of Maryland


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.